Breaking News
0

ACADIA Pharmaceuticals Inc (ACAD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow ACADIA's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25.420 +1.160    +4.78%
17/06 - Closed. Currency in USD ( Disclaimer )
After Hours
25.420
0.000
0.000%
18:09:54 - Real-time Data
Type: Equity
Market: United States
ISIN: US0042251084 
CUSIP: 004225108
  • Volume: 1,479,894
  • Bid/Ask: 24.810 / 25.750
  • Day's Range: 24.380 - 25.620
ACADIA 25.420 +1.160 +4.78%

ACAD Overview

 
Information about the ACADIA Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close24.26
Day's Range24.38 - 25.62
Revenue237.89M
Open24.62
52 wk Range12.77 - 28.67
EPS - 2.09
Volume1,479,894
Market Cap3.66B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)1,071,278
P/E RatioN/A
Beta2.89
1-Year Change61.6%
Shares Outstanding144,165,923
Next Earnings DateAug 05, 2019
What is your sentiment on ACADIA?
or
Market is currently closed. Voting is open during market hours.

ACADIA Pharmaceuticals Inc News


ACADIA Pharmaceuticals Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Buy Strong Buy Buy Buy
Technical Indicators Strong Sell Neutral BUY Sell Strong Buy
Summary Strong Sell Neutral Strong Buy Neutral Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bullish 15 Current
Harami Cross 15 Current
Completed Patterns
Engulfing Bearish 1M 2 Apr 19
Homing Pigeon 5H 2 Jun 17, 2019 05:00AM
Deliberation Bearish 1M 3 Mar 19

ACADIA Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 25.420 24.810 25.750 1,479,894 +4.78% USD 17/06  
  CBOE 25.42 0.00 0.00 0 +0.00% USD 17/06  
  Berlin 22.180 22.340 23.215 0 +4.35% EUR 02:08:00  
  Stuttgart 21.400 22.425 23.315 0 0.00% EUR 17/06  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 193.89 194.96 192.17 +1.15 +0.60% 14.67M 17/06  
  Facebook 189.01 189.50 184.41 +7.68 +4.24% 29.46M 17/06  
  Alphabet A 1,093.89 1,101.28 1,088.00 +7.59 +0.70% 988.49K 17/06  
  Tesla 225.03 227.00 214.27 +10.11 +4.70% 12.32M 17/06  
  Amazon.com 1,886.03 1,895.69 1,875.45 +16.36 +0.88% 2.63M 17/06  
  Alibaba ADR 159.92 160.55 157.47 +1.82 +1.15% 15.93M 17/06  
  AMD 29.20 30.45 29.18 -1.16 -3.82% 70.87M 17/06  
  Beyond Meat 169.96 171.19 160.61 +18.48 +12.20% 14.16M 17/06  
  Microsoft 132.85 133.73 132.53 +0.40 +0.30% 14.52M 17/06  
  Weibo Corp 41.61 41.93 41.02 +0.20 +0.48% 981.97K 17/06  

ACADIA Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

465

Equity Type

ORD

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist (SSIA), preferentially targeting 5-HT2A receptors. The Company is conducting a Phase II trial, referred to as the SERENE Study, designed to examine the efficacy and safety of pimavanserin as a treatment for Alzheimer's disease (AD) Agitation. It is also conducting a Phase III, six-week, randomized, double-blind, placebo-controlled, multi-center, outpatient study, referred to as the ENHANCE-1 study, designed to examine the use of pimavanserin in patients with schizophrenia.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Cyprus Securities and Exchange Commission (Cyprus), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia) $200 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ACAD Comments

Write your thoughts about ACADIA Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Aditya Chopra
Aditya Chopra Apr 09, 2018 8:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why doesn’t the management come out and clarify?
Jet Fly
Jet Fly Jan 23, 2018 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If ACAD breaks $33.45 resistance, it reaches $48 by end of March.
Pedro Martinez Sanz
Pedro Martinez Sanz Dec 23, 2016 1:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
29$, is buy or sell ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email